DASHENLIN PHARMACEUTICAL GROUP financial statements, including revenue, expenses, profit, and loss

The total revenue of 603233 for the last quarter is 6.73 B CNY, and it's 0.67% lower compared to the previous quarter. The net income of Q1 24 is 398.45 M CNY.